dihydroxyphenylalanine has been researched along with Carcinoma, Medullary in 10 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sesti, A | 1 |
| Mayerhoefer, M | 1 |
| Weber, M | 1 |
| Anner, P | 1 |
| Wadsak, W | 1 |
| Dudczak, R | 1 |
| Haug, A | 1 |
| Karanikas, G | 1 |
| Pestourie, C | 1 |
| Thézé, B | 1 |
| Kuhnast, B | 1 |
| Le Helleix, S | 1 |
| Gombert, K | 1 |
| Dollé, F | 1 |
| Tavitian, B | 1 |
| Ducongé, F | 1 |
| Ambrosini, V | 2 |
| Marzola, MC | 2 |
| Rubello, D | 2 |
| Fanti, S | 2 |
| Pelizzo, MR | 1 |
| Ferdeghini, M | 1 |
| Toniato, A | 1 |
| Massaro, A | 1 |
| Gross, MD | 1 |
| Al-Nahhas, A | 1 |
| Luster, M | 1 |
| Karges, W | 1 |
| Zeich, K | 1 |
| Pauls, S | 1 |
| Verburg, FA | 1 |
| Dralle, H | 1 |
| Glatting, G | 1 |
| Buck, AK | 1 |
| Solbach, C | 1 |
| Neumaier, B | 1 |
| Reske, SN | 1 |
| Mottaghy, FM | 1 |
| Soussan, M | 1 |
| Nataf, V | 1 |
| Kerrou, K | 1 |
| Grahek, D | 1 |
| Pascal, O | 1 |
| Talbot, JN | 1 |
| Montravers, F | 1 |
| Treglia, G | 1 |
| Castaldi, P | 1 |
| Rufini, V | 1 |
| Beuthien-Baumann, B | 1 |
| Strumpf, A | 1 |
| Zessin, J | 1 |
| Bredow, J | 1 |
| Kotzerke, J | 1 |
| Koopmans, KP | 1 |
| de Groot, JW | 1 |
| Plukker, JT | 1 |
| de Vries, EG | 1 |
| Kema, IP | 1 |
| Sluiter, WJ | 1 |
| Jager, PL | 1 |
| Links, TP | 1 |
| Hoegerle, S | 1 |
| Altehoefer, C | 1 |
| Ghanem, N | 1 |
| Brink, I | 1 |
| Moser, E | 1 |
| Nitzsche, E | 1 |
1 trial available for dihydroxyphenylalanine and Carcinoma, Medullary
| Article | Year |
|---|---|
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Huma | 2001 |
9 other studies available for dihydroxyphenylalanine and Carcinoma, Medullary
| Article | Year |
|---|---|
Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fo | 2014 |
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Ne | 2010 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Com | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxy | 2010 |
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Pr | 2010 |
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multim | 2012 |
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; | 2013 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; M | 2007 |
18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Dihydroxyphenylalanine; Fem | 2008 |